Filing Details

Accession Number:
0000904454-15-000215
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-17 16:41:43
Reporting Period:
2015-03-17
Filing Date:
2015-03-17
Accepted Time:
2015-03-17 16:41:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1457612 Genocea Biosciences Inc. GNCA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190418 J Stephen Hoffman C/O Skyline Ventures
303 Wyman Street, Suite 300
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-17 700,000 $8.25 1,992,415 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
Footnotes
  1. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. Stephen J. Hoffman is a director of Genocea Biosciences, Inc. (the "Issuer") and a member of Skyline Venture Partners V, L.P. To the extent that he is deemed to share voting and investment powers with respect to the shares held by Skyline Venture Partners V, L.P., Dr. Hoffman disclaims beneficial ownership of all such shares and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes, except to the extent of his proportionate pecuniary interest therein.
  2. Upon the closing of the Issuer's public offering, 700,000 shares of common stock were issued to Skyline Venture Partners V, L.P. at the public offering price of $8.25 per share.